PRRT2 and B-cell chronic lymphocytic leukemia: Although experiments have shown that inhibition of this PKC isozyme is not overtly cytotoxic to CLL cells [148], the fact that it is potentially regulating Btk function may be important to their pathophysiology [148, 149].